Join the club for FREE to access the whole archive and other member benefits.

A real tumour printed from patient's own cells to predict best cancer therapies


Key points from article :

Scientists extract a chunk of the tumour from the brain of a glioblastoma patient and use it to print a model matching their MRI scans, said Ronit Satchi-Fainaro, lead researcher.

Used to test the efficacy of potential treatments before using them for real inside the body.

Patient’s blood is pumped through the printed tumour, followed by a drug or therapeutic treatment.

Researchers say they are the first to print a viable tumour.

“We have about two weeks [to] test all the therapies..., and get back with which treatment is predicted to be the best fit,” - Satchi-Fainaro.

A treatment is deemed promising if the printed tumour shrinks or if it lowers metabolic activity against control groups.

More recent innovations have focused on bioprinting, which uses live cells as a sort of ink to build up the layers.

Study by Tel Aviv University published in the journal Science Advances.

Overcomes a long trial and error process and accelerates personalized treatment

Mentioned in this article:

Tap on icon for description, click on resource name for more details.


Head of Cancer Research and Nanomedicine Laboratory at Tel Aviv University.


Journal that publishes original research and reviews in all disciplines of science


Public Research university.